Burkina Faso vs Sierra Leone: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Burkina Faso
- Sierra Leone
How they compare
Burkina Faso currently reports 4,383 deaths against 4,079 deaths in Sierra Leone, a difference of 304 deaths.
That makes Burkina Faso's figure about 1.1 times Sierra Leone's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Sierra Leone ahead.
Burkina Faso ranks 41st and Sierra Leone ranks 44th of 157 countries.
Burkina Faso has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Burkina Faso | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,688 deaths | 163.18 deaths | 1,524 deaths | Burkina Faso |
| 2010s | 4,403 deaths | 1,770 deaths | 2,633 deaths | Burkina Faso |
| 2020s | 4,350 deaths | 3,547 deaths | 803.24 deaths | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Burkina Faso or Sierra Leone?
- Burkina Faso, at 4,383 deaths against 4,079 deaths in Sierra Leone as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Burkina Faso and Sierra Leone?
- 304 deaths, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Sierra Leone?
- 35 years are reported by both, from 1990 to 2024.
- How do Burkina Faso and Sierra Leone rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Burkina Faso ranks 41st and Sierra Leone ranks 44th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.